This is why we don’t just take the inferences from our maps of biology and send them into clinical trials. The FDA has a lot of useful restrictions on testing drugs in humans that ensure that everyone does a ton of work to minimize risk of experimenting in humans. For example, we do numerous validation experiments in human cells, animal models and preclinical models after our AI gives us input but before we go into trials and many of these experiments address safety. That said, one can never minimize risk to zero and we take our responsibility to patients seriously.